The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Factor V Cambridge: A New Mutation (Arg306→Thr) Associated With Resistance to Activated Protein C
Abstract
A new factor V mutation associated with resistance to activated protein C and thrombosis (factor V Cambridge, Arg306→Thr) was found in one patient from a carefully selected group of 17 patients with venous thrombosis and confirmed APC resistance in the absence of the common Gln506 mutation. The Arg306 mutation was also present in a first degree relative who also had APC resistance. Other potential causes of APC resistance, such as a mutation at the Arg679 site and the factor V HR2 haplotype, were excluded. Subsequent screening of 585 patients with venous thromboembolism and 226 blood donors did not show any other individual with this mutation. Factor VThr306 is the first description of a mutation affecting the Arg306 APC cleavage site and is the only mutation, other than factor V Leiden (Arg506→Gln), that has been found in association with APC resistance. This finding confirms the physiologic importance of the Arg306 APC-cleavage site in the regulation of the prothrombinase complex. It also supports the concept that APC resistance and venous thrombosis can result from a variety of genetic mutations affecting critical sites in the factor V cofactor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Poort, Sr., Rosendaal, F., Reitsma, P., & Bertina, R. (1996) · Blood · doi:10.1182/blood.v88.10.3698.bloodjournal88103698 · Cited by 3,079
Dahlbäck, B., Carlsson, M., & Svensson, P. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1004 · Cited by 1,945
Koster, T., Vandenbroucke, J., Rosendaal, F., de Ronde, H., Briët, E., & Bertina, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80081-9 · Cited by 1,239
Resistance to Activated Protein C as a Basis for Venous Thrombosis
Svensson, P. J., & Dahlback, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402243300801 · Cited by 1,102
Rosendaal, F., Koster, T., Vandenbroucke, J., & Reitsma, P. (1995) · Blood · doi:10.1182/blood.v85.6.1504.bloodjournal8561504 · Cited by 1,004
The role of phospholipids and factor Va in the prothrombinase complex.
Rosing, J., Tans, G., Govers-Riemslag, J. W., Zwaal, R. F., & Hemker, H. C. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86294-4 · Cited by 668
Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V
Voorberg, J., Roelse, J., Mertens, K., van Mourik, J. A., Koopman, R., Büller, H., Berends, F., & ten Cate, J. W. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92939-4 · Cited by 426
Anticoagulant protein C pathway defective in majority of thrombophilic patients [see comments]
Griffin, J., Evatt, B., Wideman, C., & Fernandez, J. (1993) · Blood · doi:10.1182/blood.v82.7.1989.1989 · Cited by 417
The mechanism of inactivation of human factor V and human factor Va by activated protein C.
Kalafatis, M., Rand, M. D., & Mann, K. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31776-9 · Cited by 405
Cited by
Genetic Susceptibility to Venous Thrombosis
Seligsohn, U., & Lubetsky, A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441607 · Cited by 822
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
Lane, D. A., & Grant, P. J. (2000) · Blood · doi:10.1182/blood.v95.5.1517.005k48_1517_1532 · Cited by 495
Kujovich, J. L. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3181faa0f2 · Cited by 419
Risk Factors for Venous Thrombotic Disease
Rosendaal, F. R. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615887 · Cited by 375
de Visser, M. C. H., Rosendaal, F. R., & Bertina, R. M. (1999) · Blood · doi:10.1182/blood.v93.4.1271 · Cited by 308
Metadata
- Authors
- Williamson, D., Brown, K., Luddington, R., Baglin, C., & Baglin, T.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1998-02-15
- Volume
- 91
- Issue
- 4
- Pages
- 1140-1144
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1510008853
- Cited by
- 288
- References
- 19
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Factor V Cambridge: A New Mutation (Arg306→Thr) Associated With Resistance to Activated Protein C. https://app.cochat.ai/papers/10.1182/blood.v91.4.1140
- The paper
- Williamson, D., Brown, K., Luddington, R., Baglin, C., & Baglin, T. (1998). Factor V Cambridge: A New Mutation (Arg306→Thr) Associated With Resistance to Activated Protein C. Blood. https://doi.org/10.1182/blood.v91.4.1140
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.